Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-13Clinical Trial Update: A Study of TAS-120 in Patients With Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating TAS-120 (futibatinib) in metastatic breast cancer with FGFR1 high amplification or FGFR2 amplification was termin…
-
CLINICAL_TRIALS other · 2025-11-13Clinical Trial Update: A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer [NA]
Update on a Phase II study of the TheraBionic P1 Device for hormone receptor-positive, HER2-negative breast cancer, with recruitment not yet…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: Developing Screening Clinical Breast Examination Implementation Strategies in Nigeria
This clinical trial update from Yale University outlines strategies for implementing screening clinical breast examination in Nigeria to imp…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors
A clinical trial update describing biomarkers and clinical features of metastatic breast cancer in patients treated with CDK4/6 inhibitors; …
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: Breast Re-irradiation After Second Ipsilateral Lumpectomy [NA]
This document provides an update on a clinical trial evaluating breast re-irradiation after a second ipsilateral lumpectomy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer [NA]
This clinical trial update describes an early stress-reduction intervention for patients newly diagnosed with breast cancer, with the study …
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: Ultrahypofractionation and Normal Tissue Toxicity [NA]
This clinical trial update from Massachusetts General Hospital discusses ultrahypofractionation radiotherapy for breast cancer and its impac…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: Core Biopsies for Establishing a Breast Tumor Tissue Repository
A trial update describing core biopsy collection to establish a breast tumor tissue repository; currently recruiting at the University of So…
-
CLINICAL_TRIALS other · 2025-11-13Clinical Trial Update: A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) [Phase 1]
Phase I, open-label multicenter trial evaluating safety, tolerability, and pharmacokinetics of selumetinib (AZD6244) in cancer patients; cur…
-
FDA approval · 2025-11-12FDA Tentative Approval: FLUOROURACIL — Supplemental Application (Gland Pharma Limited)
FDA Tentative Approval for Fluorouracil from Gland Pharma Limited under an ANDA, indicating a pathway to U.S. market subject to regulatory t…
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: A Study of LY3484356 in Women With Breast Cancer Before Having Surgery [Phase 1]
Phase 1 trial update for LY3484356 in women with breast cancer before surgery; the study is completed and results have been posted.
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer [Phase 3]
Phase 3 clinical trial update about promoting breast cancer screening in women who survived childhood cancer; the study is currently active …
-
CLINICAL_TRIALS trial_result · 2025-11-12Clinical Trial Update: Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer [Phase 2]
A Phase 2 trial of abemaciclib for surgically resectable, chemotherapy-resistant triple-negative breast cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer [Phase 1, Phase 2]
Roche-sponsored Phase 1/2 study evaluating multiple immunotherapy-based treatment combinations in HR-positive, HER2-negative breast cancer h…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease [NA]
This clinical trial update reports on a study evaluating curcumin for reducing joint pain in breast cancer survivors experiencing aromatase …
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors [NA]
This clinical trial update describes preparing FIM-BCS, a lifestyle modification program for African-American breast cancer survivors, with …
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
The HOPE study for older breast cancer patients, sponsored by City of Hope Medical Center, is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating trastuzumab deruxtecan, alone or in combination with anastrozole, for early-stage HER2-low, hormone rece…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma [NA]
A clinical trial evaluating whether lymphovenous bypass performed before axillary lymph node surgery can reduce the risk of lymphedema in pa…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Neratinib in Combination With Ruxolitinib in Patients With mTNBC [EARLY_Phase 1]
An early-phase trial is investigating the combination of neratinib and ruxolitinib for metastatic triple-negative breast cancer and is curre…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Tai Chi Effects on Chronic Insomnia in Breast Cancer Survivors: Immune Mechanisms [NA]
This clinical trial evaluates whether Tai Chi can improve chronic insomnia in breast cancer survivors and explores associated immune mechani…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer [NA]
A pilot feasibility study to evaluate MRI imaging of TMEM in patients with operable breast cancer; currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer [Phase 1]
BeOne Medicines is conducting a Phase 1 trial evaluating BGB-21447, a Bcl-2 inhibitor, in combination regimens for adults with hormone recep…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: A Phase Ib Study of Novel Combination (New) of Low Dose Oral CyclophoSphamide (s) to Potentiate Axatilimab (A) + Retifanlimab (R) in Treating Metastatic Triple Negative Breast Cancer (TNBC) [Phase 1]
Phase Ib study evaluating a low-dose oral cyclophosphamide to potentiate axatilimab and retifanlimab in metastatic triple-negative breast ca…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Excision Followed by Radiofrequency Ablation for Breast Cancer [NA]
This clinical trial update from the University of Arkansas evaluates excision followed by radiofrequency ablation for breast cancer, with th…